A weekly summary of Novamind news and media
FEATURES February 19, 2021
Dr. Reid Robison on Our Purpose-Driven Mission to Help People who are Suffering
Agoracom interviewed our Chief Medical Officer about our latest expansions, the striking results from treatments, and what it takes to build infrastructure for psychedelic-assisted healthcare.
FEATURES February 18, 2021
Novamind Leading the Charge to Deliver Mental Health Alternatives
Psychedelic Invest published an article about the urgent need for innovative mental health treatments, and the companies working to meet that need.
Novamind Announces Symbol Change on OTC Market To “NVMDF”
February 19, 2021
Follow @novamind_inc on Instagram
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca
Tags: COMPASS PATHWAYS, CSE, Field Trip Health Ltd., MIND MEDICINE (MINDMED) INC, NUMINUS WELLNESS INC